Skip to Main Content

Author Details

Stacy W Gray
City of Hope Comprehensive Cancer Center
1998
90
31
PMIDPaper TitleJournal TitlePublished Year
37791544Preparing for the unexpected: Recommendations for returning secondary findings in late-stage cancer care.Genet Med2024
36383274Neighborhood disadvantage is associated with KRAS-mutated non-small cell lung cancer risk.J Cancer Res Clin Oncol2023
38001574Moving the Needle Forward in Genomically-Guided Precision Radiation Treatment.Cancers (Basel)2023
37308126Private Payer and Medicare Coverage Policies for Use of Circulating Tumor DNA Tests in Cancer Diagnostics and Treatment.J Natl Compr Canc Netw2023
37373756Integrating Early-Stage Drug Development with Clinical Networks; Challenges and Opportunities: The City of Hope Developing Experience.J Clin Med2023
36797152Liquid Biopsy Screening for Early Detection of Lung Cancer: Current State and Future Directions.Clin Lung Cancer2023
34991968A Lung Cancer Screening Education Program Impacts both Referral Rates and Provider and Medical Assistant Knowledge at Two Federally Qualified Health Centers.Clin Lung Cancer2022
35617031Cross-sectional clinical cancer genomics community of practice survey analysis of provider attitudes and beliefs regarding the use of deceased family member tissue to guide living family member genetic cancer risk assessment.J Genet Couns2022
35755401A Framework for Promoting Diversity, Equity, and Inclusion in Genetics and Genomics Research.JAMA Health Forum2022
36078743The Role of Neighborhood Air Pollution Exposure on Somatic Non-Small Cell Lung Cancer Mutations in the Los Angeles Basin (2013-2018).Int J Environ Res Public Health2022
36049148Leveraging an Informatics Approach to Identify an Unmet Clinical Need for <i>BRCA1</i>/<i>2</i> Testing Among Patients With Ovarian Cancer.JCO Clin Cancer Inform2022
35175857Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion.J Clin Oncol2022
32537684Oncologists' perceptions of the usefulness of cancer survivorship care plan components.Support Care Cancer2021
33640299Therapeutic Potential of Olaparib in Combination With Pembrolizumab in a Young Patient With a Maternally Inherited BRCA2 Germline Variant: A Research Report.Clin Lung Cancer2021
33858029Germline mutations and age at onset of lung adenocarcinoma.Cancer2021
33797955Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (SWOG S1400GEN).JCO Oncol Pract2021
34442385Personalized Cancer Medicine in the Media: Sensationalism or Realistic Reporting?J Pers Med2021
34088750The Association between Polluted Neighborhoods and <i>TP53</i>-Mutated Non-Small Cell Lung Cancer.Cancer Epidemiol Biomarkers Prev2021
33970688Accessing Targeted Therapies: A Potential Roadblock to Implementing Precision Oncology?JCO Oncol Pract2021
34355454Recall of Genomic Testing Results Among Patients with Cancer.Oncologist2021
33430334Integrating Academic and Community Cancer Care and Research through Multidisciplinary Oncology Pathways for Value-Based Care: A Review and the City of Hope Experience.J Clin Med2021
32923869Oncologist Confidence in Genomic Testing and Implications for Using Multimarker Tumor Panel Tests in Practice.JCO Precis Oncol2020
31899533Association of Physician Peer Influence With Subsequent Physician Adoption and Use of Bevacizumab.JAMA Netw Open2020
31863816Circulating tumor DNA as an early cancer detection tool.Pharmacol Ther2020
33183308Factors influencing cancer genetic somatic mutation test ordering by cancer physician.J Transl Med2020
32634780Private Payer and Medicare Coverage for Circulating Tumor DNA Testing: A Historical Analysis of Coverage Policies From 2015 to 2019.J Natl Compr Canc Netw2020
33002444Demystifying the estimand framework: a case study using patient-reported outcomes in oncology.Lancet Oncol2020
32923887Engaging Patients in Precision Oncology: Development and Usability of a Web-Based Patient-Facing Genomic Sequencing Report.JCO Precis Oncol2020
30728895The effects of genomic germline variant reclassification on clinical cancer care.Oncotarget2019
31008900Influence of Peer Physicians on Intensity of End-of-Life Care for Cancer Decedents.Med Care2019
29315417Interactive or static reports to guide clinical interpretation of cancer genomics.J Am Med Inform Assoc2018
35135159Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United States.JCO Precis Oncol2018
30264921Factors contributing to disparities in mortality among patients with non-small-cell lung cancer.Cancer Med2018
30339520Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing.J Clin Oncol2018
29618041Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry.J Natl Cancer Inst2018
29635808Cancer drug shortages: Awareness and perspectives from a representative sample of the US population.Cancer2018
29381410What Does a Cancer Diagnosis Mean? Public Expectations in a Shifting Therapeutic Environment.J Oncol Pract2018
28070939Oncologists' perspectives on post-cancer treatment communication and care coordination with primary care physicians.Eur J Cancer Care (Engl)2017
28125075Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study.Genet Med2017
28095174Medical Oncologists' Experiences in Using Genomic Testing for Lung and Colorectal Cancer Care.J Oncol Pract2017
28589610Consumer Perspectives on Access to Direct-to-Consumer Genetic Testing: Role of Demographic Factors and the Testing Experience.Milbank Q2017
28757884The fuzzy world of precision medicine: deliberations of a precision medicine tumor board.Per Med2017
27937091Personal Genomic Testing for Cancer Risk: Results From the Impact of Personal Genomics Study.J Clin Oncol2017
26865455Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.Cancer Immunol Res2016
27650835Quality in the Age of Precision Medicine: The Clinician Perspective.J Oncol Pract2016
27392080Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.Am J Hum Genet2016
27579639CLINICAL PROBLEM-SOLVING. Tip of the Tongue.N Engl J Med2016
27460824The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.Genome Med2016
27459981Pediatric Oncology Provider Views on Performing a Biopsy of Solid Tumors in Children with Relapsed or Refractory Disease for the Purpose of Genomic Profiling.Ann Surg Oncol2016
27181682Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.Am J Hum Genet2016
  • 1 - 50 of 90

Recommended Authors

Emory University
Career Start Year 2018
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 0
Biomedical Ethics Program, Mayo Clinic
Career Start Year 2014
Number of shared co-authors 15
National Cancer Institute, National Institutes of Health
Career Start Year 2014
Number of shared co-authors 2
VA Salt Lake City Healthcare System (VINCI)
Career Start Year 2013
Number of shared co-authors 5
Vanderbilt University Medical Center
Career Start Year 2013
Number of shared co-authors 9
Kaiser Permanente Center for Health Research
Career Start Year 2012
Number of shared co-authors 40
Google
Career Start Year 2012
Number of shared co-authors 15
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 2011
Number of shared co-authors 0
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 2010
Number of shared co-authors 2
Northwestern University
Career Start Year 2010
Number of shared co-authors 4
Vanderbilt University Medical Center
Career Start Year 2009
Number of shared co-authors 12
Kaiser Permanente
Career Start Year 2008
Number of shared co-authors 0
USA University of California at San Francisco, Institute for Health and Aging
Career Start Year 2007
Number of shared co-authors 21
Rush University Cancer Center, Rush University Medical Center
Career Start Year 2007
Number of shared co-authors 6
Genomic Medicine Institute, Geisinger Medical Center
Career Start Year 2005
Number of shared co-authors 27
Kaiser Permanente Washington Health Research Institute
Career Start Year 2005
Number of shared co-authors 23
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 2
National Institutes of Health
Career Start Year 2004
Number of shared co-authors 18
Marti Nelson Cancer Foundation
Career Start Year 2003
Number of shared co-authors 3
Massachusetts General Hospital
Career Start Year 2003
Number of shared co-authors 6
Neaman Center for Personalized Medicine, NorthShore University HealthSystem
Career Start Year 2000
Number of shared co-authors 7
Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 24
Research Institute
Career Start Year 1997
Number of shared co-authors 25
Department of Medicine and Moores Cancer Center, University of California San Diego.
Career Start Year 1994
Number of shared co-authors 3
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 7
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1993
Number of shared co-authors 14
College of Medicine, The Ohio State University
Career Start Year 1992
Number of shared co-authors 9
Deverka Consulting LLC
Career Start Year 1991
Number of shared co-authors 21
University of Pennsylvania
Career Start Year 1991
Number of shared co-authors 1

Collaborators

Broad Institute of Harvard and MIT
Co-authored papers 10
Dana-Farber Cancer Institute
Co-authored papers 10
Medical Ethics and Health Policy, University of Pennsylvania
Co-authored papers 9
Dana-Farber Cancer Institute
Co-authored papers 9
Dana-Farber Cancer Institute
Co-authored papers 8
University of Washington Medical Center
Co-authored papers 6
Baylor College of Medicine
Co-authored papers 6
Dana-Farber Cancer Institute
Co-authored papers 5
Illumina Inc.
Co-authored papers 5
Brigham and Women's Hospital, Broad Institute Ariadne Labs and Harvard Medical School
Co-authored papers 5
The Heart Institute, Cincinnati Children's Hospital Medical Center
Co-authored papers 4
University of Washington School of Medicine, University of Washington
Co-authored papers 4
The Broad Institute of MIT and Harvard
Co-authored papers 4
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 4
University of North Carolina at Chapel Hill
Co-authored papers 4
School of Public Health.
Co-authored papers 4
Baylor College of Medicine.
Co-authored papers 4
University of North Carolina
Co-authored papers 4
University of North Carolina
Co-authored papers 4
Boston Children's Hospital, Harvard Medical School
Co-authored papers 4
Institute for Health Metrics and Evaluation, University of Washington
Co-authored papers 4
Biomedical Ethics, Mayo Clinic and Foundation
Co-authored papers 4
Harvard Medical School, Vanderbilt University, Yale University Yale Law School
Co-authored papers 3
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Co-authored papers 3
University of Michigan Medical School.
Co-authored papers 3
University of California-San Francisco.
Co-authored papers 3
Norton Children's Research Institute Affiliated with the University of Louisville
Co-authored papers 3
University of Washington
Co-authored papers 3
Institute for Public Health Genetics, University of Washington
Co-authored papers 3
Thomas Jefferson University
Co-authored papers 3